Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Annual Review of Medicine|November 7, 2017
Targeting RAGE Signaling in Inflammatory DiseaseBarry I Hudson, Marc E LippmanPharmaceutical Research|August 5, 2004
RAGE: a novel target for drug intervention in diabetic vascular diseaseBarry I Hudson, Ann Marie SchmidtPlos One|November 22, 2013
Alternative splicing of the RAGE cytoplasmic domain regulates cell signaling and functionJoel Jules, Dony Maiguel, Barry I HudsonArthritis Research & Therapy|July 1, 2005
Soluble RAGE: a hot new biomarker for the hot joint?Bernhard Moser, Barry I Hudson, Ann Marie SchmidtFrontiers in Bioscience (Landmark Edition)|May 31, 2011
Alternative splicing of RAGE: roles in biology and diseaseAnastasia Z Kalea, Ann Marie Schmidt, Barry I HudsonClinical Science (London, England : 1979)|March 12, 2009
RAGE: a novel biological and genetic marker for vascular diseaseAnastasia Z Kalea, Ann Marie Schmidt, Barry I HudsonThe Journal of Biological Chemistry|March 30, 2016
Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell FunctionAlex Braley, Taekyoung Kwak, Joel Jules, et al.Rheumatology (Oxford, England)|July 11, 2009
Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseasesHélène Maillard-Lefebvre, Eric Boulanger, Maïté Daroux, et al.Cellular Immunology|March 6, 2012
RAGE binds C1q and enhances C1q-mediated phagocytosisWanchao Ma, Vivek Rai, Barry I Hudson, et al.Cancer Research|June 24, 2010
Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signalingAnastasia Z Kalea, Fiona See, Evis Harja, et al.Pageof 5